Who We Are


William Tom Amick

Mr. William Thomas Amick served as the Chief Executive Officer and President of Dendreon Corp. Prior to Dendreon, he was the Chief Executive Officer of Discovery Laboratories and Executive Chairman and CEO of Aldagen, Inc. Previously, during his highly successful 30-year career at the Johnson & Johnson, Tom was instrumental in establishing its biotechnology/oncology business. After starting the biotechnology/oncology business within J&J, he advanced to the position of a Vice President of the Oncology Franchise, where he developed one of the most successful businesses in the history of J&J. Tom also held positions of increasing responsibility including, the President of Janssen Inc. and President of Ortho Biotech Europe, when he oversaw the operation of separate companies in Germany, France, Italy, England and Canada. He ended his career at J&J as the Vice President of J&J Development Corp. He served as Key Advisor at Affinergy, Inc. Tom was also a Venture Partner at Pappas Ventures. He serves as a Member of Advisory Board at Intersouth Partners. He has been a Member of the Board of Directors at Biolex Inc, and as a Member of Advisory Board at Quaker BioVentures. Tom holds a BA degree in business administration from Elon College and has attended executive courses at the Kellogg School of Management, Harvard Business School and Darden School of Business.